The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat

Prostaglandins
P J Piper, M N Samhoun

Abstract

The biological actions of pure slow-reacting substance of anaphylaxis (SRS-A) from guinea-pig lung, pure slow-reacting substance (SRS) from rat basophilic leukaemia cells (RBL-1) and synthetic leukotrienes C4 (LTC4) and D4 (LTD4) have been investigated on lung tissue from guinea pig, rabbit and rat. In the guinea pig, the leukotrienes released cyclo-oxygenase products from the perfused lung and contracted strips of parenchyma. The effects of SRS-A, SRS and LTD4 were indistinguishable. LTC4 and LTD4 had similar actions although LTD4 was more potent than LTC4. Indomethacin (1 microgram/ml) inhibited the release of cyclo-oxygenase products from perfused guinea-pig lung and caused a marked reduction in contractions of guinea-pig parenchymal strips (GPP) due to LTC4 and LTD4. The residual contraction of the GPP was abolished by FPL 55712 (0.5 - 1.0 microgram/ml). It appears, therefore, that a major part of the constrictor actions of LTC4 and LTD4 in guinea-pig lung are mediated by myotropic cyclo-oxygenase products, i.e. thromboxane A2 (TxA2) and prostaglandins (PGs). In rabbit and rat lung, however, SRS-A, SRS and the leukotrienes were much less potent in contracting parenchymal strips and there was little evidence of the release o...Continue Reading

References

Apr 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L OrningB Samuelsson
Mar 7, 1980·European Journal of Pharmacology·F Al-Ubaidi, Y S Bakhle
May 1, 1980·Prostaglandins·T J Williams, P J Piper
May 1, 1963·Acta Physiologica Scandinavica·E ANGGARD, S BERGSTROM
Aug 1, 1964·British Journal of Pharmacology and Chemotherapy·P A BERRY, H O COLLIER

❮ Previous
Next ❯

Citations

May 1, 1985·Die Naturwissenschaften·D Piomelli
Oct 1, 1989·Zeitschrift für Kardiologie·J Fauler, J C Frölich
Jan 1, 1986·The Journal of Membrane Biology·B E Schaeffer, J A Zadunaisky
Dec 17, 1982·Pharmaceutisch Weekblad. Scientific Edition·F P Nijkamp, J M Sitsen
Oct 1, 1984·Agents and Actions·A G StewartM R Fennessy
Jan 1, 1985·Lung·A B MalikK E Burhop
Jan 13, 1984·Biochemical and Biophysical Research Communications·J B Cheng, R G Townley
Dec 15, 1984·Biochemical Pharmacology·J H FleischW S Marshall
Dec 24, 1982·European Journal of Pharmacology·S E DahlénS Hammarström
Jul 13, 1984·European Journal of Pharmacology·B R CreeseW M Bothwell
Sep 3, 1984·European Journal of Pharmacology·K G MugridgeS Moncada
May 12, 1993·European Journal of Pharmacology·T YamaguchiY Iizuka
Dec 12, 1994·European Journal of Pharmacology·P NormanP J Gardiner
Mar 15, 1987·Thrombosis Research·J Filep, E Földes-Filep
Dec 1, 1981·Prostaglandins·E W SpannhakeP J Kadowitz
Aug 1, 1982·Prostaglandins·B M Weichman, S S Tucker
Jan 1, 1983·Prostaglandins·D F WoodwardM A Wasserman
Jan 1, 1984·Prostaglandins·J StjernschantzM Sears
Jan 1, 1985·Prostaglandins·P J PiperL J McLeod

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.